Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Somatostatin Receptor-positive GEP-NET × lutetium Lu 177 dotatate × 1 year × Clear all

Sponsor

Conditions

Neuroendocrine Tumors 18 Meningioma 5 Gastro-enteropancreatic neuroendocrine tumor 5 Adenoma, Islet Cell 3 Pheochromocytoma 2 Paraganglioma 2 Somatostatinoma 1 Somatostatin Receptor-positive Neuroendocrine Tumor 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Neuroblastoma 1 Neoplasms, Germ Cell and Embryonal 1 Neoplasms 1 Metastatic Digestive System Neuroendocrine Tumor G1 1 Medulloblastoma 1 Hypertension 1 Glioma 1 Glioblastoma 1 Extensive Stage Small Cell Lung Cancer 1 Ependymoma 1 Disease Progression 1 Digestive System Neuroendocrine Tumor G1 1 Diffuse Intrinsic Pontine Glioma 1 Central Nervous System Neoplasms 1 Carcinoma, Neuroendocrine 1 Carcinoma, Merkel Cell 1 Carcinoid Tumor 1 Advanced Neuroendocrine Neoplasm 1 Advanced Lung Neuroendocrine Tumor 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡